Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

bioMerieux Acquires Chinese Rapid Test Manufacturer Meikang Biotech

By Pharmaceutical Processing | January 14, 2010

bioMerieux announced today the acquisition of the rapid testmanufacturer, Meikang Biotech, and its large production site in Shanghai. Thisimportant milestone will reinforce bioMerieux’s position in the Point of Careand rapid test markets for both emerging and developed countries. Theacquisition highlights bioMerieux’s continued business expansion infast-growing emerging markets, giving the company fully-owned, integratedmanufacturing and R&D capabilities in China. “With this acquisition, we are gaining a strategic foothold in China, thecountry that should drive the most growth in the next 10 years, andsignificant assets to enhance our product offering for Point of Care, asegment with a double digit annual growth rate. We are now poised to become amajor player in Point of Care with manual rapid tests including the QuickVuerange and the automated handheld device from our Philips partnership announcedlast week,” said Stephane Bancel, bioMerieux Chief Executive Officer. “Thisalso represents a significant step in the globalization of our company:bioMerieux will now have leaders based in three corporate hubs, in Marcyl’Etoile, France, Cambridge, USA and Shanghai, China.”

Related Articles Read More >

Building a resilient pharma supply chain
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE